Post by
mercedesman on Mar 21, 2022 9:35am
Interesting....
...a pinch hitting bean counter that has experience as a VP Finance of a Company that was acquired by another Company?
Seems like Seto was looking for some pretty specific knowledge/M&A experieince from the perspective of the acquiree, vs a long time CFO who can run a couple of distribution Companies.
Failing that, the new guy is familiar with the reporting/listing requirements of a Nasdaq listed company.
Which fork in the road will Seto take as the two Trials/FDA move inexorably toward completion?
Hmmmm?!?
MM
Comment by
Domino55 on Mar 21, 2022 12:05pm
This to me looks like another administrative release. It is sufficiently vague. Is it a subtle indicator of where things are headed? Hard to say in the context of the blind puzzle. Real news is long overdue.
Comment by
mercedesman on Mar 21, 2022 12:16pm
I'm guessing that there will be 1 - 2 puzzle peices released by the end of this week (worst case, the week following)
Comment by
Domino55 on Mar 21, 2022 12:52pm
MM I'm not sure we get real news until we get this gentleman suited up with options. Hopefully he has been loaded up and we can move forward.
Comment by
mercedesman on Mar 21, 2022 12:59pm
Thought about that. If he was worth his salt, he would already have negotiated that in his contract. Otherwise he has a small but specific role to play IMO. Material developments can only be sat on for so long. MM